SOTERA HEALTH COMPANY Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests
SOTERA HEALTH COMPANY (SHC) reported Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests of $2.80 million for the 16-month period ending 2022-09-30, per its 10-Q filed 2022-11-02.
Discontinued › Shareholders' Equity
us-gaap:MinorityInterestDecreaseFromRedemptions · last filed 2024-02-27
- SOTERA HEALTH COMPANY noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2021-12-31 was $0.00.
- SOTERA HEALTH COMPANY noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2021-09-30 was $0.00.
- SOTERA HEALTH COMPANY noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2021-06-30 was $8.58M.
- SOTERA HEALTH COMPANY noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2021 was $8.58M.
| Period end | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 1 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 3 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 4 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 6 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 9 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 10 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 12 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 13 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 16 month |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | $2.80M 10-Q · filed 2022-11-02 | ||||||||
| 2022-06-30 | $2.80M 10-Q · filed 2022-08-04 | ||||||||
| 2022-03-31 | $2.80M 10-Q · filed 2022-05-05 | ||||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $8.58M derived: sum of 3 quarters · filed 2024-02-27 | $8.58M 10-K · filed 2024-02-27 | |||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $2.80M 10-K · filed 2023-02-28 | $8.58M derived: sum of 2 quarters · filed 2022-11-02 | $8.58M 10-Q · filed 2022-11-02 | |||||
| 2021-06-30 | $2.80M 10-Q · filed 2021-08-12 | $8.58M 10-Q · filed 2022-08-04 | $8.58M 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |